To date, the CAD assessment primarily relies on indicators such as the presence or absence of angina during rest or exercise, electrocardiogram changes, CK-MB, troponins, and NT-proBNP (Zhang et al., 2020). This evidence concerns the gene NPPB and coronary artery disorder.